Analysis of protease‐activated receptor‐1 and ‐2 in human scar formation
暂无分享,去创建一个
D. Massi | M. Paglierani | M. Santucci | F. Tarantini | G. Cirino | C. Serio | P. Geppetti | F. Carraro | A. Naldini | S. Materazzi | S. Pellerito | C. Di Serio | C. Ardinghi
[1] D. Greenhalgh,et al. Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.
[2] M. Artuc,et al. Expression of prothrombin, thrombin and its receptors in human scars , 2006, Experimental dermatology.
[3] George Broughton,et al. The Basic Science of Wound Healing , 2006, Plastic and reconstructive surgery.
[4] M. Hollenberg,et al. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. , 2005, Human pathology.
[5] Bishara S Atiyeh,et al. Keloid or Hypertrophic Scar: The Controversy: Review of the Literature , 2005, Annals of plastic surgery.
[6] R. Johns,et al. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. , 2005, The American journal of pathology.
[7] A. Mukhopadhyay,et al. Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast‐populated collagen lattices , 2005, The British journal of dermatology.
[8] David W. Johnson,et al. Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells. , 2005, Kidney international.
[9] A. Masamune,et al. Protease-Activated Receptor-2-Mediated Proliferation and Collagen Production of Rat Pancreatic Stellate Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.
[10] Jianhua Zhang,et al. Protease-activated receptor-2 (PAR-2) expression in human fibroblasts is regulated by growth factors and extracellular matrix. , 2004, The Journal of investigative dermatology.
[11] M. Longaker,et al. Complex epithelial–mesenchymal interactions modulate transforming growth factor‐β expression in keloid‐derived cells , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[12] Giulio Gabbiani,et al. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.
[13] N. Bunnett,et al. Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.
[14] V. Moulin,et al. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors , 2004, Journal of cellular physiology.
[15] G. Caliendo,et al. PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation , 2004, Hepatology.
[16] A. Desmoulière,et al. Normal and Pathologic Soft Tissue Remodeling: Role of the Myofibroblast, with Special Emphasis on Liver and Kidney Fibrosis , 2003, Laboratory Investigation.
[17] L. Gesualdo,et al. Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis. , 2003, Journal of the American Society of Nephrology : JASN.
[18] G. Gabbiani,et al. The myofibroblast in wound healing and fibrocontractive diseases , 2003, The Journal of pathology.
[19] M. Gaca,et al. Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. , 2002, Journal of hepatology.
[20] S. Kuptsova,et al. Immobilized Thrombin Receptor Agonist Peptide Accelerates Wound Healing in Mice , 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[21] S. Phan,et al. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. , 2001, Current pharmaceutical design.
[22] M. D'Andrea,et al. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. , 2001, The American journal of pathology.
[23] W. Timens,et al. Keratinocyte‐derived growth factors play a role in the formation of hypertrophic scars , 2001, The Journal of pathology.
[24] G. D. Hunter,et al. Proteinase-activated receptors. , 2001, Pharmacological reviews.
[25] M. Longaker,et al. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. , 2001, Plastic and reconstructive surgery.
[26] F. Carraro,et al. Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation , 1999, Journal of cellular physiology.
[27] M Kon,et al. On the nature of hypertrophic scars and keloids: a review. , 1999, Plastic and reconstructive surgery.
[28] P. C. van de Kerkhof,et al. Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study , 1998, The Journal of pathology.
[29] G. Saed,et al. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. , 1998, Archives of dermatology.
[30] I. Leigh,et al. Activated keratinocytes in the epidermis of hypertrophic scars. , 1998, The American journal of pathology.
[31] S. M. Baker,et al. Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[32] T. K. Hunt,et al. Mice lacking the thrombin receptor, PAR1, have normal skin wound healing. , 1997, The American journal of pathology.
[33] A. Ghahary,et al. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. , 1997, The Surgical clinics of North America.
[34] C. Derian,et al. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Phan,et al. Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. , 1995, The Journal of investigative dermatology.
[36] R. Diegelmann,et al. Keloid fibroblasts exhibit an altered response to TGF-beta. , 1992, The Journal of investigative dermatology.
[37] M. Robson,et al. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. , 1992, The Journal of clinical investigation.
[38] V. Wheaton,et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.
[39] M. Hollenberg,et al. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[40] Rintala Ae. Keloid or Hypertrophic scar , 1996 .